Christopher W. Peer

Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.

Mario A. Anzano, Stephen W. Byers, Joseph M. Smith et al. · PubMed · 1994 · 198 citations

Breast Oncology, Pathology, Tumor Biology +16

Chemoprevention of Mammary Carcinogenesis in the Rat: Combined Use of Raloxifene and 9-cis-Retinoic Acid

Mario A. Anzano, Christopher W. Peer, Joseph M. Smith et al. · JNCI Journal of the National Cancer Institute · 1996 · 171 citations

Breast Oncology, Chemoprevention Strategy, Medicine +12

1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.

Mario A. Anzano, Joseph M. Smith, Milan R. Uskoković et al. · PubMed · 1994 · 137 citations

Medicinal Chemistry, Oncology, Endocrine-related Cancer +15

Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.

Nanjoo Suh, Andrew L. Glasebrook, Alan D. Palkowitz et al. · PubMed · 2001 · 104 citations

Medicinal Chemistry, Breast Oncology, Pharmacological Study +15

Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.

M. Scott Lucia, Mario A. Anzano, M. V. Slayter et al. · PubMed · 1995 · 96 citations

Chemoprevention Strategy, Gynecology, Pharmacotherapy +21